LITTLETON, Colo. - Vivos Therapeutics, Inc. (NASDAQ: VVOS), a company specializing in treatments for sleep-related breathing disorders, announced today that the American Medical... ByInvesting.com ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Oil & Gas, Technology and Basic Materials sectors led shares higher. At the close in NYSE, the ...

At close: November 8 at 4:00 PM EST ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Featured here, the Balance Sheet for Vivos Therapeutics Inc, which summarises the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...